Verve

Gene Editing Developing therapies to safely edit the adult genome and confer lifelong protection from cardiovascular disease https://www.vervetx.com Press Releases Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A...

eGenesis

eGenesis Gene Editing Press Releases eGenesis Announces $100M Series B Financing Nov 7, 2019 eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel Jun 11, 2019 eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive...